Challenges with risk mitigation in academic drug discovery: finding the best solution.

Anuradha Roy
Author Information
  1. Anuradha Roy: a High Throughput Screening laboratory , University of Kansas , Lawrence , KS , USA.

Abstract

No abstract text available.

Keywords

References

  1. Science. 2004 Nov 12;306(5699):1138-9 [PMID: 15542455]
  2. Chem Biol. 2010 Jun 25;17(6):561-77 [PMID: 20609406]
  3. Curr Top Med Chem. 2011;11(10):1275-83 [PMID: 21401506]
  4. J Med Chem. 2013 Sep 26;56(18):7161-76 [PMID: 23672690]
  5. Nat Rev Drug Discov. 2013 Nov;12(11):811-2 [PMID: 24172316]
  6. PLoS One. 2014 Sep 16;9(9):e107006 [PMID: 25225870]
  7. Nat Rev Drug Discov. 2014 Dec;13(12):875-6 [PMID: 25435205]
  8. Cell. 2015 Jun 4;161(6):1252-65 [PMID: 26046436]
  9. Nat Rev Drug Discov. 2015 Nov;14(11):733-4 [PMID: 26388229]
  10. Expert Opin Drug Discov. 2017 Jun;12(6):537-540 [PMID: 28394189]
  11. J Hematol Oncol. 2017 May 12;10(1):106 [PMID: 28499452]
  12. ACS Chem Biol. 2018 Jan 19;13(1):36-44 [PMID: 29202222]
  13. Toxicol In Vitro. 2018 Apr;48:262-275 [PMID: 29408671]
  14. High Throughput. 2018 Feb 09;7(1):null [PMID: 29485615]
  15. Nat Biotechnol. 2018 Sep 6;36(9):798 [PMID: 30188525]

Grants

  1. P20 GM113117/NIGMS NIH HHS
  2. P30 CA168524/NCI NIH HHS

MeSH Term

Drug Discovery
Drug Industry
High-Throughput Screening Assays
Humans
Risk Management

Word Cloud

Created with Highcharts 10.0.0drugdiscoveryChallengesriskmitigationacademicdiscovery:findingbestsolutionProbeacademia-pharmahighthroughputscreening

Similar Articles

Cited By